Posted in | News | Nanoenergy

First Solar to Expand Production Capacity of Advanced Thin-Film PV Modules

First Solar, Inc. (Nasdaq: FSLR) today announced plans to build two new four-line manufacturing plants that will boost the company’s annual manufacturing capacity by nearly 500 MW to help meet strong demand for its advanced thin-film photovoltaic modules.

The plants are expected to be built in the United States and Vietnam and completed in 2012. Each new plant will create approximately 600 green jobs and will be designed to accommodate additional production capacity. Negotiations and site assessments are ongoing in both countries and will be finalized and announced at a later date.

The new factories will further extend First Solar’s previously announced capacity additions, including eight lines at its Kulim, Malaysia facility, four lines in Frankfurt an der Oder, Germany, and two lines in Blanquefort, France. Earlier this year the company also completed an expansion of its Perrysburg, Ohio, manufacturing plant, which serves as First Solar’s primary hub for engineering, research and development, and employs more than 1,100 of First Solar’s 1,500+ U.S.-based associates. The new plants announced today, combined with these previously announced expansions, will nearly double production capacity from 1.4 GW in 2010 to more than 2.7 GW in 2012.

“These expansions provide proximity to growing U.S. demand while supporting our roadmap to drive down the cost of clean, sustainable solar electricity,” said First Solar CEO Rob Gillette. “Effective government policies provide long-term visibility and enable sustainable markets.”

In addition to the increase in manufacturing employment, First Solar expects to generate over 1,000 construction jobs through the installation of solar power plants from the company’s 2.2 GW North American project pipeline.

Source: http://www.firstsolar.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.